Cambridge, Massachusetts
United States
8
2023-08-03
8
2025-05-20
These are the the leading inventors for applications assigned to BIONTECH US INC.:
BIONTECH US INC. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Protein antigens and uses thereof
#2 | 2022-06-09 ✅ Patent 12,258,581 granted on 2025-03-25T cell manufacturing compositions and methods
#3 | 2021-11-04 ✅ Patent 12,331,097 granted on 2025-06-17T CELL RECEPTOR CONSTRUCTS AND USES THEREOF
#4 | 2021-09-02 ✅ Patent 12,246,067 granted on 2025-03-11Neoantigens and uses thereof
#5 | 2021-06-17 ✅ Patent 11,793,867 granted on 2023-10-24Neoantigens and uses thereof
#6 | 2020-09-03 ✅ Patent 11,183,272 granted on 2021-11-23Method and systems for prediction of HLA class II-specific epitopes and characterization of CD4+ T cells
#7 | 2020-05-28 ✅ Patent 11,162,072 granted on 2021-11-02T cell manufacturing compositions and methods
#8 | 2020-03-26 ✅ Patent 11,965,892 granted on 2024-04-23HLA-based methods and compositions and uses thereof
Also check out BioNTech US Inc.'s (Cambridge, United States) applicant profile with 12 patent applications submitted.
595262 ⎘